but other companies seem to be validating their idea as legit.
Which brings us to the larger point I made a long time ago. There is nothing about this product that makes it difficult to duplicate. Any substantial company can duplicate QDXHID in a matter of days and almost certainly have a better product - something that is becoming increasingly clear with QMC now being months after beta-testing was supposed to be done with, and they are still finding problems they didn't know about.
So, not only will other companies have a better product faster despite the later start, competitors like Abbott or IBM will also have every possible advantage over QMC in the market.